Zobrazeno 1 - 10 of 42 pro vyhledávání: '"Cellular bone allograft"'
1
Akademický článek
A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)
Autor: Bradley Wetzell, Julie B. McLean, Kimberly Dorsch, Mark A. Moore
Publikováno v: Journal of Orthopaedic Surgery and Research, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background The objectives of this study were to build upon previously-reported 12-month findings by retrospectively comparing 24-month follow-up hospitalization charges and potentially-relevant readmissions in US lumbar fusion surgeries that
Externí odkaz: https://doaj.org/article/d826b565be034d27911084479b6ada76
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Lumbar spine fusion outcomes using a cellular bone allograft with lineage-committed bone-forming cells in 96 patients
Autor: Hossein Elgafy, Bradley Wetzell, Marshall Gillette, Hassan Semaan, Andrea Rowland, Christopher A. Balboa, Thomas A. Mierzwa, Julie B. McLean, Kimberly Dorsch, Mark A. Moore
Publikováno v: BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Instrumented posterior lumbar fusion (IPLF) with and without transforaminal interbody fusion (TLIF) is a common treatment for low back pain when conservative interventions have failed. Certain patient comorbidities and lifestyle r
Externí odkaz: https://doaj.org/article/31a4ca5d25e94105b3ee3d23651ba9d9
Zobrazit plný text záznamu
4
Akademický článek
A large database study of hospitalization charges and follow-up re-admissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)
Autor: Bradley Wetzell, Julie B. McLean, Mark A. Moore, Venkateswarlu Kondragunta, Kimberly Dorsch
Publikováno v: Journal of Orthopaedic Surgery and Research, Vol 15, Iss 1, Pp 1-13 (2020)
Abstract Background The objective of this study was to retrospectively compare initial procedure and 12-month follow-up hospitalization charges and resource utilization (lengths of stay; LOS) for lumbar fusion surgeries using either recombinant human
Externí odkaz: https://doaj.org/article/df6b95eb3f584e869a30157998d0e25a
Zobrazit plný text záznamu
5
Akademický článek
Multilevel instrumented posterolateral lumbar spine fusion with an allogeneic cellular bone graft
Autor: John F. Hall, Julie B. McLean, Savannah M. Jones, Mark A. Moore, Michelle D. Nicholson, Kimberly A. Dorsch
Publikováno v: Journal of Orthopaedic Surgery and Research, Vol 14, Iss 1, Pp 1-9 (2019)
Abstract Background Low back pain (LBP) is the leading cause of absence from work, disability, and impaired quality of life. Fusion surgery may be indicated when non-operative treatments have failed to provide relief. Surgery may include the use of f
Externí odkaz: https://doaj.org/article/1244a2ca2ecd445da4689e622d568a27
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2
Autor: Daniel Dongwhan Lee, John Yongmin Kim
Publikováno v: Journal of Orthopaedic Surgery and Research, Vol 12, Iss 1, Pp 1-8 (2017)
Abstract Background Both the map3 Cellular Allogeneic Bone Graft® and recombinant human bone morphogenetic protein 2 (rhBMP-2, Infuse®) were developed to provide an alternative to iliac crest autograft, thus eliminating the morbidity associated wit
Externí odkaz: https://doaj.org/article/106e58f9825f4484be33011cf536ca23
Zobrazit plný text záznamu
8
Lumbar spine fusion outcomes using a cellular bone allograft with lineage-committed bone-forming cells in 96 patients
Autor: Hassan Semaan, Bradley Wetzell, Julie B McLean, Christopher A Balboa, Andrea Rowland, Marshall Gillette, Thomas A Mierzwa, Kimberly Dorsch, Mark A Moore, Hossein Elgafy
Publikováno v: BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-10 (2021)
BMC Musculoskeletal Disorders
Background Instrumented posterior lumbar fusion (IPLF) with and without transforaminal interbody fusion (TLIF) is a common treatment for low back pain when conservative interventions have failed. Certain patient comorbidities and lifestyle risk facto
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec242aa0dc8b7064e57ceb83e384e23
https://doaj.org/article/31a4ca5d25e94105b3ee3d23651ba9d9
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
A large database study of hospitalization charges and follow-up re-admissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)
Autor: Kimberly Dorsch, Bradley Wetzell, Mark A. Moore, Venkateswarlu Kondragunta, Julie B. McLean
Publikováno v: Journal of Orthopaedic Surgery and Research
Journal of Orthopaedic Surgery and Research, Vol 15, Iss 1, Pp 1-13 (2020)
Background The objective of this study was to retrospectively compare initial procedure and 12-month follow-up hospitalization charges and resource utilization (lengths of stay; LOS) for lumbar fusion surgeries using either recombinant human bone mor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6d9c016c56efc4682dbdad0defe109
https://pubmed.ncbi.nlm.nih.gov/33213484
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje